Sort
17,054 grants matching “genome editing”
Elucidation of mutant p53-medidated mechanisms in promoting metastatic esophageal cancer
$46,843Gizem Efe · Columbia University Health Sciences · F31 · FY2023 · CA
Dissecting how gene regulatory redundancy ensures robustness of mammalian development
$46,770Joshua Andrei Alcantara · University Of California-Irvine · F31 · FY2025 · HD
Interrogating the role of mutant KRAS allelic imbalance and co-mutated genes in targeted therapy response of NSCLC
$46,752Bianca Diaz · Weill Medical Coll Of Cornell Univ · F31 · FY2022 · CA
Determining the cell fate programs of mammalian retina development
$46,752Martin Tran · California Institute Of Technology · F31 · FY2022 · EY
The conserved transcription factor UNC-30/PITX1-3 coordinates synaptogenesis and cell identity in C. elegans motor neurons
$46,752Edgar Orlando Correa-Colãn · University Of Chicago · F31 · FY2022 · NS
Defining the role of the nuclear lamina in the mechanical regulation of lung fibrosis
$46,752Emma Carley · Yale University · F31 · FY2022 · HL
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
$46,752Axel O Vera · Massachusetts Institute Of Technology · F31 · FY2022 · GM
Biochemical studies of aberrant chromatin regulation in cancer
$46,752Nicholas Prescott · Weill Medical Coll Of Cornell Univ · F99 · FY2022 · CA
Characterization of P. falciparum gametocyte-essential genes using a novel genetic screen
$46,752Sean Taylor Windle · Seattle Children'S Hospital · F31 · FY2022 · AI
Elucidating the RNA-mediated mechanisms governing H3K9me3 deposition in fragile X syndrome
$46,752Thomas Ernst Malachowski · University Of Pennsylvania · F31 · FY2022 · NS
Understanding the divergent functions of mutant p53
$46,752Margaret Kennedy · Sloan-Kettering Inst Can Research · F31 · FY2022 · CA
Progeria and Vasculature: Investigating Genetic Effects and the Potential of Genome Editing for Treatment
$46,752Crystal Kennedy · Duke University · F31 · FY2022 · HL
Dynamics of Mitochondrial Inheritance in C. elegans Primordial Germ Cells
$46,752Aaron Zachary Schwartz · New York University School Of Medicine · F31 · FY2022 · HD
Defining mechanisms of lipoprotein turnover and their regulation by ASGR1
$46,752Tabea Moll · Johns Hopkins University · F31 · FY2022 · HL
Role of TREM2 R47H in Alzheimer's disease using novel CRISPR/Cas9 mouse models
$46,735Paul Ja-Wen Cheng-Hathaway · Case Western Reserve University · F30 · FY2016 · AG
Decoding Alzheimer's disease-related enhancers in microglia
$46,730Bethany Rose Fixsen · University Of California, San Diego · F30 · FY2021 · AG
Exploiting RNAi-based silencing of Myc and metabolic vulnerabilities to prevent relapse after Kras inhibition in lung cancer
$46,691Ankur Sheel · Univ Of Massachusetts Med Sch Worcester · F30 · FY2019 · CA
Genome Engineered Natural Killer Cell Immunotherapy against Human Osteosarcoma
$46,683Gabrielle Matilde Robbins · University Of Minnesota · F30 · FY2024 · OD
Nanoparticle delivery of triplex-forming PNAs for thalassemia gene therapy
$46,590Nicole McNeer · Yale University · F30 · FY2011 · HL
Genetic Technology Fabrication and Development Core
$46,567David L Van Vactor · Harvard Medical School · P01 · FY2020 · NS
Leveraging Tissue-Specific Regulatory Grammar to Interpret Human Evolution and Non-coding Variation
$46,114Steven K. Reilly · Harvard University · F32 · FY2019 · HG
Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease
$46,094Alexandra Munch · Icahn School Of Medicine At Mount Sinai · F31 · FY2023 · AG
Functional Role for H3 Serotonylation During Critical Periods of Postnatal Brain Development and Plasticity
$46,094Ashley Cunningham · Icahn School Of Medicine At Mount Sinai · F31 · FY2023 · NS
Functional and Transcriptional Mechanisms of Familial Brugada Syndrome
$46,073Kevin R. Bersell · Vanderbilt University · F30 · FY2017 · HL
Alzheimer's Disease Genetic Risk and Microglial Innate Immune Memory
$46,060Zena Chatila · Columbia University Health Sciences · F30 · FY2021 · AG